IGX — Intelgenx Technologies Share News
0.000.00%
Last trade - 00:00- CA$41.92m
- CA$62.83m
- $1.04m
Brief: IntelGenx Ships CBD Filmstrips To Heritage Cannabis In Support Of Canadian Market Launch
Brief: IntelGenx Reports Q2 2021 Financial Results
Brief: Intelgenx Strengthens Board With The Appointments Of Dr. Srinivas G. Rao And Frank Stegert
Brief: IntelGenx Announces Noteholder Approval Of Proposed Amendments To Convertible Notes
Brief: Intelgenx Reports First Quarter 2021 Financial Results
Brief: IntelGenx Expands Psychedelics Collaboration With atai Life Sciences
Brief: IntelGenx Announces Intention To Amend Convertible Unsecured Promissory Notes
Brief: Intelgenx Reports Fourth Quarter And Full-Year 2020 Financial Results
Brief: atai Life Sciences AG Announces Equity Investment In And Strategic Partnership With IntelGenx Technologies Corp
Brief: IntelGenx Gets USPTO Notice Of Allowance For Novel DisinteQ-Based Disintegrating THC Oral Film
Brief: Intelgenx Receives First Purchase Order For Cbd Filmstrips From Heritage Cannabis
Brief: Intelgenx Reports Q3 2020 Financial Results
Brief: Intelgenx Signs Letter Of Intent With Heritage Cannabis For Long-Term Cannabis Filmstrip Supply Agreement
Brief: Intelgenx Enters Into Amended And Restated License Agreement With Tetra Bio-Pharma For Adversa Mucoadhesive Delivery Technology For Dronabinol
Brief: Intelgenx And Exeltis Healthcare Expand Rizaport Commercialization Agreement To Include European Union
Brief: Intelgenx Technologies Reports Second Quarter 2020 Financial Results
Brief: Intelgenx Says Got Clarity From FDA On CMC Information Required For Resubmission Of NDA For Acute Migraines Treatment
Brief: Intelgenx Receives Health Canada Cannabis Micro-Processing License
Brief: Intelgenx To Issue Shares In Payment Of Principal On Outstanding Debentures